EDITORIAL


Call for a Global Vaccine Plan to Combat Current and Future Pandemics: One for ALL and ALL for One



Salim Surani1, *, Pahnwat T. Taweesedt2, Sara Surani3, Iqbal Ratnani4, Joseph Varon5
1 Medicine & Pharmacology Texas A&M University, College Station, Texas, 77843, USA Research Collaborator, Mayo Clinic, Rochester, MN USA
2 Pulmonary Associates Corpus Christi, Texas, 78404, USA
3 Tsinghua University, Global Affairs, Beijing, China Pulmonary Associates, Corpus Christi, Texas, 78413, USA
4 Weil Cornell University Houston Methodist Hospital, Houston Texas, 77030, USA
5 The University of Texas Health Science Center at Houston, University of Texas, Medical Branch at Galveston, Chief of Critical Care Services, United Memorial Medical Center / United General Hospital, Houston, Texas, USA


Article Metrics

CrossRef Citations:
0
Total Statistics:

Full-Text HTML Views: 184
Abstract HTML Views: 84
PDF Downloads: 0
ePub Downloads: 0
Total Views/Downloads: 268
Unique Statistics:

Full-Text HTML Views: 122
Abstract HTML Views: 56
PDF Downloads: 0
ePub Downloads: 0
Total Views/Downloads: 178



Creative Commons License
© 2022 Surani et al.

open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

* Address correspondence to this author at the Medicine & Pharmacology Texas A&M University, College Station, Texas, 77843, USAResearch Collaborator, Mayo Clinic, Rochester, MNUSA; E-mail: srsurani@hotmail.com


Editorial

The emergence of SARS-CoV-2 in late December 2019 has taken the world by storm. In March 2020, the World Health Organization (WHO) named this virus COVID-19. To date, it has infected approximately 186 million people worldwide and is attributed as the cause of death of more than 5 million people (and this number is only increasing.) The global effort to develop vaccines and therapeutics occurred at the fastest pace yet, with several vaccines' approval under emergency authorization use. There are also several post-marketing side effects, including myocarditis, cerebral venous embolism, and Guillain Barre Syndrome. Global vaccine disparity complicates the control of pandemic challenges. Several highly infectious variants have emerged, and more variants are feared to emerge if global vaccination plans are not developed soon.

Keywords: Vaccines, mRNA Vaccines, SARS-CoV-2, COVID-19, Cerebral venous embolism, Delta variant, Myocarditis.